Glenmark Pharmaceuticals has submitted a copy of Press Release dated October 25, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/g’.
The above information is a part of company’s filings submitted to BSE.